celecoxib has been researched along with Hyperlipemia in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study is to assess the effects of celecoxib and sulfasalazine on the risk of coronary artery disease (CAD) in patients with ankylosing spondylitis (AS)." | 7.83 | Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: A nation-wide, population-based case-control study. ( Chiou, JY; Leong, PY; Li, TY; Wang, YH; Wei, JC; Wu, LC; Yeo, KJ, 2016) |
| "The aim of the study is to assess the effects of celecoxib and sulfasalazine on the risk of coronary artery disease (CAD) in patients with ankylosing spondylitis (AS)." | 3.83 | Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: A nation-wide, population-based case-control study. ( Chiou, JY; Leong, PY; Li, TY; Wang, YH; Wei, JC; Wu, LC; Yeo, KJ, 2016) |
| "We explored whether hyperlipidemia or combination of hyperlipidemia and E2 could induce TMJOA." | 1.91 | Combination of hyperlipidemia and 17β-Estradiol induces TMJOA-like pathological changes in rats. ( Gan, YH; Zhao, Y, 2023) |
| "Eosinophilic fasciitis (EF) is a rare connective tissue disorder characterized by symmetrical sclerodermatous skin changes primarily affecting the extremities and histologically, by thickening of the fascia with chronic inflammatory infiltrate containing eosinophils." | 1.34 | Eosinophilic fasciitis in a 57-year-old Japanese-American woman. ( Ambrocio, DU; Uramoto, K, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Y | 1 |
| Gan, YH | 1 |
| Ekor, M | 1 |
| Owusu Agyei, PE | 1 |
| Obese, E | 1 |
| Biney, RP | 1 |
| Henneh, IT | 1 |
| Antwi-Adjei, M | 1 |
| Yahaya, ES | 1 |
| Amoakohene, G | 1 |
| Akakpo, PK | 1 |
| Wu, LC | 1 |
| Leong, PY | 1 |
| Yeo, KJ | 1 |
| Li, TY | 1 |
| Wang, YH | 1 |
| Chiou, JY | 1 |
| Wei, JC | 1 |
| Triadafilopoulos, G | 1 |
| Lombard, CM | 1 |
| Jobe, BA | 1 |
| Ambrocio, DU | 1 |
| Uramoto, K | 1 |
5 other studies available for celecoxib and Hyperlipemia
| Article | Year |
|---|---|
Combination of hyperlipidemia and 17β-Estradiol induces TMJOA-like pathological changes in rats.
Topics: Animals; Celecoxib; Chondrocytes; Cyclooxygenase 2; Estradiol; Female; Hyperlipidemias; NF-kappa B; | 2023 |
Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemia.
Topics: Animals; Atorvastatin; Celecoxib; Cholesterol; Coconut Oil; Disease Models, Animal; Hyperlipidemias; | 2021 |
Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: A nation-wide, population-based case-control study.
Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Case-Control Studies; Celecoxib; Coronary Artery Dis | 2016 |
"War and Peace" with Barrett's esophagus.
Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Antihypertensive Agents; Aspirin; Barrett Esophagus; Celeco | 2011 |
Eosinophilic fasciitis in a 57-year-old Japanese-American woman.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Diagnosis, Differential; Eosinophilia; Fasciitis | 2007 |